Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study.
Martella F, Cerrano M, Di Cuonzo D, Secreto C, Olivi M, Apolito V, D'Ardia S, Frairia C, Giai V, Lanzarone G, Urbino I, Freilone R, Giaccone L, Busca A, Dellacasa CM, Audisio E, Ferrero D, Beggiato E. Martella F, et al. Among authors: ferrero d, d ardia s. Ann Hematol. 2022 Apr;101(4):855-867. doi: 10.1007/s00277-022-04770-6. Epub 2022 Feb 7. Ann Hematol. 2022. PMID: 35128571
Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients.
Brunello L, Passera R, Dellacasa CM, Giaccone L, Audisio E, Ferrero D, D'Ardia S, Allione B, Aydin S, Festuccia M, Lia G, Crisà E, Maffini E, Butera S, Busca A, Bruno B. Brunello L, et al. Among authors: ferrero d, d ardia s. Ann Hematol. 2018 Nov;97(11):2205-2215. doi: 10.1007/s00277-018-3433-3. Epub 2018 Jul 9. Ann Hematol. 2018. PMID: 29987350 Clinical Trial.
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs.
Crisà E, Venturino E, Passera R, Prina M, Schinco P, Borchiellini A, Giai V, Ciocca Vasino MA, Bazzan M, Vaccarino A, Boccadoro M, Ferrero D. Crisà E, et al. Among authors: ferrero d. Ann Hematol. 2010 Jul;89(7):691-9. doi: 10.1007/s00277-009-0899-z. Epub 2010 Feb 10. Ann Hematol. 2010. PMID: 20146064 Free article.
Can pegylated interferon improve the outcome of polycythemia vera patients?
Crisà E, Cerrano M, Beggiato E, Benevolo G, Lanzarone G, Manzini PM, Borchiellini A, Riera L, Boccadoro M, Ferrero D. Crisà E, et al. Among authors: ferrero d. J Hematol Oncol. 2017 Jan 13;10(1):15. doi: 10.1186/s13045-017-0395-1. J Hematol Oncol. 2017. PMID: 28086927 Free PMC article.
FLAI induction regimen in elderly patients with acute myeloid leukemia.
Cerrano M, Candoni A, Crisà E, Dubbini MV, D'Ardia S, Zannier ME, Boccadoro M, Audisio E, Bruno B, Ferrero D. Cerrano M, et al. Among authors: ferrero d, d ardia s. Leuk Lymphoma. 2019 Dec;60(13):3339-3340. doi: 10.1080/10428194.2019.1620943. Epub 2019 Jun 4. Leuk Lymphoma. 2019. PMID: 31159609 Free article. No abstract available.
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation.
Apolito V, Giaccone L, Ferrero S, Larocca A, Cavallo F, Coscia M, Beggiato E, Butera S, Martella F, Dainese C, Cetani G, Scaldaferri M, Cattel F, Boccadoro M, Ferrero D, Bruno B, Cerrano M. Apolito V, et al. Among authors: ferrero s, ferrero d. Ann Hematol. 2020 Sep;99(9):2197-2199. doi: 10.1007/s00277-020-04180-6. Epub 2020 Jul 13. Ann Hematol. 2020. PMID: 32661577 No abstract available.
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021.
Urbino I, Secreto C, Olivi M, Apolito V, D'Ardia S, Frairia C, Giai V, Aydin S, Freilone R, Dellacasa C, Giaccone L, Ferrero D, Audisio E, Busca A, Cerrano M. Urbino I, et al. Among authors: ferrero d, d ardia s. Cancers (Basel). 2021 Oct 11;13(20):5075. doi: 10.3390/cancers13205075. Cancers (Basel). 2021. PMID: 34680226 Free PMC article. Review.
Efficacy of a combination of human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3 to improve moderate to severe anaemia in low/intermediate risk myelodysplastic syndromes.
Ferrero D, Darbesio A, Giai V, Genuardi M, Dellacasa CM, Sorasio R, Bertini M, Boccadoro M. Ferrero D, et al. Br J Haematol. 2009 Feb;144(3):342-9. doi: 10.1111/j.1365-2141.2008.07465.x. Epub 2008 Nov 19. Br J Haematol. 2009. PMID: 19036104 Free article. Clinical Trial.
Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: a retrospective study on 91 unselected patients.
Cerrano M, Crisà E, Pregno P, Aguzzi C, Riccomagno P, Boccadoro M, Ferrero D. Cerrano M, et al. Among authors: ferrero d. Am J Hematol. 2013 Oct;88(10):838-42. doi: 10.1002/ajh.23501. Epub 2013 Jul 23. Am J Hematol. 2013. PMID: 23757199 Free article. Clinical Trial.
199 results